 [10] 
  The third consideration was that a party's commercial business or scientific interests associated with trade secrets could be seriously harmed by disclosure that is open to public access. He drew a comparison with documents produced on discovery, which remain private at that stage of the litigation. Apotex argues that much of the information covered by the protective order is already in the public domain in one form or another, but I am not persuaded, as the well established practice is to rely on the good faith of the person seeking the order, without prejudice to Apotex's rights to move the Court to declassify specific documents.